Literature DB >> 20833231

Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV.

P N Koutsoudaki1, H Hildebrandt, V Gudi, T Skripuletz, J Škuljec, M Stangel.   

Abstract

Polysialic acid (PSA) is a carbohydrate polymer added post-translationally on the neural cell adhesion molecule (NCAM) affecting its adhesion properties. It has been suggested that the presence of PSA in demyelinated lesions in multiple sclerosis could prevent axon-glia interactions inhibiting spontaneous remyelination. The enzyme St8siaIV is one of the two polysialyltransferases responsible for PSA synthesis, and it is predominantly active during adult life. Here we treated 8-10-weeks old St8siaIV deficient and wild-type mice for 5 weeks with cuprizone, which is a reliable model for de- and remyelination in the corpus callosum and cortex. Developmental myelination of the St8siaIV knock-out mice was not disturbed and adult mice showed normal myelin protein expression. Demyelination did not differ between transgenic and wild-type mice but early myelin protein re-expression and thus remyelination were accelerated in St8siaIV knock-out mice during the first week after withdrawal of the toxin. This was mainly due to enhanced oligodendrocyte precursor cells (OPC) differentiation and to a lesser extent to OPC recruitment. These data are proof of principle that PSA expression interferes at least to some extent with remyelination in vivo.
Copyright © 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833231     DOI: 10.1016/j.neuroscience.2010.08.070

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

Review 1.  Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Authors:  Hong Shi; Xiaoming Hu; Rehana K Leak; Yejie Shi; Chengrui An; Jun Suenaga; Jun Chen; Yanqin Gao
Journal:  Exp Neurol       Date:  2015-03-24       Impact factor: 5.330

2.  Extensive cell migration, axon regeneration, and improved function with polysialic acid-modified Schwann cells after spinal cord injury.

Authors:  Mousumi Ghosh; Luis M Tuesta; Rocio Puentes; Samik Patel; Kiara Melendez; Abderrahman El Maarouf; Urs Rutishauser; Damien Daniel Pearse
Journal:  Glia       Date:  2012-03-27       Impact factor: 7.452

Review 3.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

Review 4.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

5.  Polysialylation at Early Stages of Oligodendrocyte Differentiation Promotes Myelin Repair.

Authors:  Sebastian Werneburg; Hazel L S Fuchs; Iris Albers; Hannelore Burkhardt; Viktoria Gudi; Thomas Skripuletz; Martin Stangel; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  J Neurosci       Date:  2017-07-31       Impact factor: 6.167

6.  A mouse model for testing remyelinating therapies.

Authors:  C Brian Bai; Sunny Sun; Andrew Roholt; Emily Benson; Dale Edberg; Satish Medicetty; Ranjan Dutta; Grahame Kidd; Wendy B Macklin; Bruce Trapp
Journal:  Exp Neurol       Date:  2016-07-03       Impact factor: 5.330

7.  ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons.

Authors:  Lukasz Mateusz Szewczyk; Nikola Brozko; Andrzej Nagalski; Iris Röckle; Sebastian Werneburg; Herbert Hildebrandt; Marta Barbara Wisniewska; Jacek Kuznicki
Journal:  Glia       Date:  2016-08-18       Impact factor: 7.452

8.  Intravenous transplantation of mouse embryonic stem cells attenuates demyelination in an ICR outbred mouse model of demyelinating diseases.

Authors:  Kidsadagon Pringproa; Anucha Sathanawongs; Chananthida Khamphilai; Sarocha Sukkarinprom; Apichart Oranratnachai
Journal:  Neural Regen Res       Date:  2016-10       Impact factor: 5.135

Review 9.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.

Authors:  Viktoria Gudi; Stefan Gingele; Thomas Skripuletz; Martin Stangel
Journal:  Front Cell Neurosci       Date:  2014-03-13       Impact factor: 5.505

Review 10.  Oligodendrogenesis in the normal and pathological central nervous system.

Authors:  Bilal El Waly; Magali Macchi; Myriam Cayre; Pascale Durbec
Journal:  Front Neurosci       Date:  2014-06-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.